• No results found

University of Groningen Biology of acute myeloid leukemia stem cells Mattes, Katharina

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Biology of acute myeloid leukemia stem cells Mattes, Katharina"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Biology of acute myeloid leukemia stem cells

Mattes, Katharina

DOI:

10.33612/diss.98637951

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Mattes, K. (2019). Biology of acute myeloid leukemia stem cells: the role of CITED2 and mitochondrial

activity. Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.98637951

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

Processed on: 23-9-2019 Processed on: 23-9-2019 Processed on: 23-9-2019

Processed on: 23-9-2019 PDF page: 1PDF page: 1PDF page: 1PDF page: 1

Katharina Mattes

Biology of acute myeloid

leukemia stem cells

(3)

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

Processed on: 23-9-2019 Processed on: 23-9-2019 Processed on: 23-9-2019

Processed on: 23-9-2019 PDF page: 2PDF page: 2PDF page: 2PDF page: 2

The studies described in this thesis were performed at the Department of Hematology of the University Medical Center Groningen, the Netherlands.

Funding: Printing of this thesis was financially supported by the University of Groningen, the UMCG Graduate School of Medical Science and the Department of Hematology.

ISBN: 978-94-028-1723-2 Cover and layout design: Gerbrig Berger

Printing: Ipskamp Drukkers BV, Enschede Copyright © 2019, Katharina Mattes

All rights reserved. No part of this thesis may be reproduced, stored or transmitted in any form or by any means without permission of the author.

(4)

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

Processed on: 23-9-2019 Processed on: 23-9-2019 Processed on: 23-9-2019

Processed on: 23-9-2019 PDF page: 3PDF page: 3PDF page: 3PDF page: 3

Biology of acute myeloid

leukemia stem cells

The role of CITED2 and mitochondrial activity

Proefschrift

ter verkrijging van de graad van doctor aan de

Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. C. Wijmenga

en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op

maandag 4 november 2019 om 14.30 uur

door

Katharina Mattes

geboren op 13 juni 1986

te Mistelbach, Oostenrijk

(5)

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

Processed on: 23-9-2019 Processed on: 23-9-2019 Processed on: 23-9-2019

Processed on: 23-9-2019 PDF page: 4PDF page: 4PDF page: 4PDF page: 4

Promotor

Prof. dr. E. Vellenga

Copromotor

Dr. H. Schepers

Beoordelingscommissie

Prof. dr. P.J. Coffer

Prof. dr. W. Helfrich

Prof. dr. G. de Haan

(6)

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

Processed on: 23-9-2019 Processed on: 23-9-2019 Processed on: 23-9-2019

Processed on: 23-9-2019 PDF page: 5PDF page: 5PDF page: 5PDF page: 5

(7)

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

Processed on: 23-9-2019 Processed on: 23-9-2019 Processed on: 23-9-2019

Processed on: 23-9-2019 PDF page: 6PDF page: 6PDF page: 6PDF page: 6

Paranymphs

Aida Rodríguez-López

Gerbrig Berger

(8)

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

Processed on: 23-9-2019 Processed on: 23-9-2019 Processed on: 23-9-2019

Processed on: 23-9-2019 PDF page: 7PDF page: 7PDF page: 7PDF page: 7

Chapter 1

General introduction

p.9

Chapter 2

CITED2 affects leukemic cell survival by

interfering with p53 activation

(Cell Death & Disease, 2017)

p.31

Chapter 3

The transcriptional regulators CITED2 and PU.1

cooperate in maintaining hematopoietic stem cells

(Experimental Hematology, 2019)

p.53

Chapter 4

Differential redox-regulation and mitochondrial

dynamics in normal and leukemic hematopoietic stem

cells: A potential window for leukemia therapy

(Critical Reviews in Oncology/Hematology, 2019, in

press)

p.79

Chapter 5

CD34

+

acute myeloid leukemia cells with low levels

of reactive oxygen species show increased expression

of stemness-genes and can be targeted by the BCL2

inhibitor Venetoclax

(submitted)

p.109

Chapter 6

Summary, discussion and future perspectives

p.129

Appendices

Dutch summary

Acknowledgements

About the author

List of publications

p.145

(9)

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

535611-L-sub01-bw-Mattes

Processed on: 23-9-2019 Processed on: 23-9-2019 Processed on: 23-9-2019

Referenties

GERELATEERDE DOCUMENTEN

(i) Expression of indicated proteins is shown for the ROS-low and ROS-high cell fraction sorted from CD34 + AML cells.. (ii) Expression of indicated proteins is shown from the

We demonstrated that ROS- low LSCs have a reduced mitochondrial content, low levels of ATP and a different gene expression signature that suggests an increased stemness

Latere gebeurtenissen in de AML- evolutie veroorzaken differentiatie- en proliferatie-afwijkingen en resulteren in de vorming van leukemische stamcellen, welke voor een

(A) mRNA expression fold change of indicated genes in the ROS-low vs the ROS-high cell fraction of normal (both CB and PBSCs) CD34 + stem- and progenitor cells (n=4).. Genes

Normal hematopoietic- and leukemic stem cells are very similar regarding their morphology, metabolic activity and gene expression, however, they have an altered

Human acute myeloid leukemia reprogramming to pluripotency is a rare event and selects for patient hematopoietic cells devoid of leukemic mutations..

Whether a stem cell divides symmetrically or asymmetrically depends on intrinsic and extrinsic factors. Research has confirmed that the interplay with the bone marrow

Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker. Schuurhuis GJ, Meel MH,